QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, June 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review

Article (August 2024)

Teneligliptin as an Adjuvant Therapy in Type 2 Diabetic Management: A Prospective Observational Study

Article in Journal of Young Pharmacists (June 2024)

Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals

Article in Metabolic Syndrome and Related Disorders (January 2024)